Redcliffe Labs Raises USD 42 Million for Expansion in India
Sep 17, 2024 17:08
Redcliffe Labs, a diagnostic services provider, secures USD 42 million for expansion into Tier II and III cities in India. The funding will be used to enhance accessibility to advanced diagnostics.
New Delhi, Sep 17 (PTI) Diagnostic services provider Redcliffe Labs on Tuesday said it has raised USD 42 million (about Rs 352 crore), which will be used for expansion across Tier II and III cities in India.
The funding round was led by Denmark's IFU (Investeringsfonden for Udviklingslande), which invested USD 20 million, followed by existing investor LeapFrog Investments with USD 15 million.
Redcliffe's existing shareholders HealthQuad and Spark Growth Ventures also invested in the round.
"This fresh injection of capital will fuel Redcliffe's expansion plans, focusing on deepening its presence in Tier II and III cities across India," a company statement said.
Founded in 2018, Redcliffe Labs offers services across more than 200 cities in India.
"With this raise, we're poised to increase accessibility to advanced diagnostic services across the nation with a commitment to empower individuals with the knowledge and tools they need to take charge of their health," Aditya Kandoi, founder and CEO, Redcliffe Labs, said.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.